BIONTECH

BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.

#SimilarOrganizations #People #Financial #Website #More

BIONTECH

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2008-01-01

Address:

Mainz, Rheinland-Pfalz, Germany

Country:

Germany

Website Url:

http://www.biontech.de

Total Employee:

1001+

Status:

Active

Contact:

+49 6131 90-840

Email Addresses:

[email protected]

Total Funding:

1.74 B USD

Technology used in webpage:

SPF Domain Not Resolving Mobile Non Scaleable Content Amazon Organization Schema IPv6 ReCAPTCHA JsDelivr Cloudflare JS US Privacy User Signal Mechanism

Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Current Advisors List

christoph-huber_image

Christoph Huber Member of the Supervisory Board @ BioNTech
Board_member

Current Employees Featured

ugur-sahin_image

Ugur Sahin
Ugur Sahin Co-Founder and CEO @ BioNTech
Co-Founder and CEO

christoph-huber_image

Christoph Huber
Christoph Huber Cofounder & deputy chair supervisory board @ BioNTech
Cofounder & deputy chair supervisory board
2008-01-01

christoph-kröner_image

Christoph Kröner
Christoph Kröner Director DNA Process Development & Cap Technology @ BioNTech
Director DNA Process Development & Cap Technology

jesse-dong_image

Jesse Dong
Jesse Dong Vice President, Peptide Chemistry @ BioNTech
Vice President, Peptide Chemistry
2020-05-01

andreas-kuhn_image

Andreas Kuhn
Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing @ BioNTech
Senior Vice President RNA Biochemistry & Manufacturing
2019-01-01

michael-boehler_image

Michael Boehler
Michael Boehler Vice President Global Commercial and General Manager @ BioNTech
Vice President Global Commercial and General Manager
2020-08-01

arvind-m-hundal-phd_image

Arvind m. Hundal Ph.d.
Arvind m. Hundal Ph.d. SVP Business Development @ BioNTech
SVP Business Development
2019-05-01

marc-wolfgang_image

Marc Wolfgang
Marc Wolfgang VP Technical Operations @ BioNTech
VP Technical Operations
2020-05-01

Founder

christoph-huber_image

Christoph Huber

ugur-sahin_image

Ugur Sahin

Stock Details

Company's stock symbol is NASDAQ:BNTX

Acquisitions List

Date	Company	Article	Price
2021-11-09	PhagoMed	PhagoMed acquired by BioNTech	N/A
2021-07-19	Kite - TCR therapy	Kite - TCR therapy acquired by BioNTech	N/A
2020-01-16	Neon Therapeutics	Neon Therapeutics acquired by BioNTech	67 M USD

Investors List

german-federal-ministry-of-education-and-research-bmbf_image

Investments List

Date	Company	Article	Money raised
2022-02-02	MediGene	BioNTech investment in Post-IPO Equity - MediGene	26 M EUR
2022-01-25	InstaDeep	BioNTech investment in Series B - InstaDeep	100 M USD

Official Site Inspections

http://www.biontech.de Semrush global rank: 291.45 K Semrush visits lastest month: 228.31 K

Host Informations
Whois Informations

Loading ...